Renovaro Biosciences Inc. (NASDAQ: RENB)
$1.41
+0.0100 ( +0.71% ) 143.7K
Renovaro Inc formerly Renovaro Biosciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.
Market Data
Open
$1.41
Previous close
$1.40
Volume
143.7K
Market cap
$218.58M
Day range
$1.39 - $1.45
52 week range
$0.66 - $5.25
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-k/a | Quarterly Reports | 7 | Oct 30, 2023 |
| 4 | Insider transactions | 1 | Oct 27, 2023 |
| 4 | Insider transactions | 1 | Oct 25, 2023 |
| 3 | Insider transactions | 1 | Oct 24, 2023 |
| 3 | Insider transactions | 1 | Oct 24, 2023 |
| 4 | Insider transactions | 1 | Oct 19, 2023 |
| 8-k | 8K-related | 13 | Oct 11, 2023 |
| 8-k | 8K-related | 14 | Oct 10, 2023 |
| 8-k | 8K-related | 13 | Oct 10, 2023 |
| 3 | Insider transactions | 1 | Oct 06, 2023 |